Akinyemi Ajayi, MD
Pediatric Pulmonology · Winter Park, FLNPI 1215915152
Payments from drug & device makers
Across 869 payments — averaging $2282.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$745K
- Jazz Pharmaceuticals Inc.$741K
- Idorsia Pharmaceuticals US Inc$221K
- Avadel CNS Pharmaceuticals, LLC$68K
- Teva Pharmaceuticals USA, Inc.$67K
- Novartis$44K
- plus $98K from 24 others
Across 6 payments — averaging $1842.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arbor Pharmaceuticals, Inc.$9K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
What the payments were for
- Consulting fees$75,63817%
- Speaking & faculty fees$289,81867%
- Travel & lodging$53,42312%
- Food & beverage$14,5113%
- Education$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 65 | $744,606 |
| Jazz Pharmaceuticals Inc. | 530 | $740,906 |
| Idorsia Pharmaceuticals US Inc | 24 | $220,526 |
| Avadel CNS Pharmaceuticals, LLC | 61 | $68,004 |
| Teva Pharmaceuticals USA, Inc. | 39 | $67,369 |
| Novartis | 16 | $44,319 |
| GSK | 13 | $36,764 |
| Harmony Biosciences LLC | 25 | $30,637 |
| AstraZeneca | 31 | $16,834 |
| Vanda Pharmaceuticals Inc. | 1 | $6,500 |
| Boehringer Ingelheim | 2 | $5,423 |
| Gilead | 4 | $402 |
| Philips North America LLC | 15 | $323 |
| Sanofi | 4 | $167 |
| Regeneron Healthcare Solutions, Inc. | 6 | $160 |
| Amgen | 1 | $123 |
| Advanced Respiratory, Inc | 6 | $106 |
| Merck | 1 | $99 |
| Sobi, Inc | 5 | $91 |
| Atricure, Inc. | 1 | $82 |
| Biogen | 3 | $66 |
| Baxter Healthcare | 3 | $58 |
| Insmed, Inc. | 1 | $53 |
| Phadia US Inc. | 3 | $52 |
| Fisher & Paykel Healthcare Inc | 3 | $41 |
| Electromed, Inc. | 2 | $28 |
| Novo Nordisk | 1 | $18 |
| Covis Pharma GmbH | 1 | $16 |
| Ambu Inc. | 1 | $13 |
| Alk-abello, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,983,800 in reported general payments places this provider in the 95th percentile of 72 pediatric pulmonology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Modafinil | 23 | $9,025 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $1,183 |
Paid to pharmacies, not to this prescriber.
Other pediatric pulmonology in Winter Park
- Kevin KuriakoseWinter Park$6K
- Shivani VermaWinter Park$3K
- Rucheet PatelWinter Park$2K
- Robert MorganWinter Park$2K
- Aledie NavasOrlando$2.5M
- Carmen Leon AstudilloGainesville$1.5M
- Deanna GreenSt Petersburg$1M
- Floyd LivingstonOrlando$1M
- Isaac TalmaciuPembroke Pines$636K
- Okan ElidemirPensacola$614K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.